Given its role as a mediator in inflammatory cascades within the brain2,4, it is likely that S100β serum levels may be modulated by multiple factors that could be independent of Alzheimer’s disease, or indirect from the dementia-associated pathology occurring in the brain. The gene discussed is S100B; the disease is early-onset autosomal dominant Alzheimer disease.